Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 6, 1998, Pages 499-505

  Planes A ^a   Vochelle, N ^a   Fagola, M ^a   Bellaud, M ^a  

^a Clinique Radio Chirurgicale du Mail   (France)

Author keywords

Deep vein thrombosis; Enoxaparin; Low molecular weight heparin; Proximal deep vein thrombosis; Reviparin; Venography

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTIVE SURGERY; FEMALE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TOTAL HIP PROSTHESIS;

EID: 0031768703     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199809000-00007     Document Type: Article

References (16)

1. Salzman EW, Hirsh J. The epidemiology, pathogenesis and natural history of venous thrombosis. In: Colman RW, Hirsch J, Marder VJ, Salzman EW (editors): Haemostasis and thrombosis: basic principles and clinical practice. Philadelphia: JB Lippincott Company; 1994. pp. 1275-1296.
2. International Consensus Statement on the Prevention of venous thromboembolism. Int Angiol Mar 1997; 16: 3-38.
3. Prandoni P, Lensing AWA, Cogo A, Cuppin S, Villalta S, Carta M, et al. The long term clinical course of acute deep vein thrombosis. Ann Intern Med 1996; 125: 1-7.
4. Parker-Williams J, Vickers R. Major orthopaedic surgery on the leg and thromboembolism. BMJ 1991; 303: 531-532.
5. Barrowcliffe TW, Johnson EA, Thomas DP (editors). Low molecular weight heparin. Chichester, UK: John Wiley, 1992.
6. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992; 79: 1-17.
7. Turpie AGG, Levine RD, Gent M, Turpie AGG, Levine MN, Hirsh J, et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925-929.
8. Nurmohamed MT, Rosendaal FR, Buller HR, Dekker E, Hommes DW, Vandenbroucke JP, et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152-156.
9. Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP. Low molecular weight heparin in prevention of perioperative thrombosis. Br Med J 1992; 305: 913-920.
10. Jorgensen LN, Wille-Jorgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704.
11. Koch A, Bouges S, Ziegler S, Dinkel H, Daures JP, Victor N. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. Br J Surg 1997; 84: 750-759.
12. Planès A, Vochelle N, Chevret S, Fagola M, Bellaud M. Dose-finding studies of reviparin in elective hip surgery. Semin Thromb Hemost 1993; 19: 44-48.
13. Planès A, Vochelle N, Mazzas F, Mansat C, Zucman J, Landais A. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988; 60: 407-410.
14. The Danish Enoxaparin Study Group. Low molecular weight heparin (enoxaparin) versus dextran 70 in the prevention of postoperative deep vein thrombosis after total hip replacement. Arch Intern Med 1991; 151: 1621-1624.
15. Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, et al. Prevention of deep vein thrombosis after elective hip surgery. Ann Intern Med 1991; 114: 545-551.
16. Azizi M, Veyssier-Belot C, Alhenc-Gelas M, Chatellier G, Billaud-Mesguish E, Fiessinger JN, et al. Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteers. Br J Clin Pharmacol 1995; 40: 577-584.